Nov 5, 9:13 PM ET
Align Technology entered an accelerated share repurchase agreement with Goldman Sachs to buy back $270 million of its common stock, funded with cash on hand. The company expects to complete the transaction by about December 29, 2026, and says the deal brings its total 2026 share repurchases to approximately $500 million.
- ASR of $270 million, with a $270 million prepayment to Goldman Sachs made under the agreement dated November 5, 2026
- Initial delivery of approximately 1.44 million shares; final share count depends on volume-weighted average price less a discount
- Approximately $330 million remains under the $1.0 billion repurchase program after this transaction; cash and equivalents were about $1.145 billion as of September 30, 2026
- Final settlement expected no later than about December 29, 2026
Read the filing on SEC.gov ↗
Oct 28, 4:02 PM ET
Align Technology said Jennifer L. Davis, former CEO of Procter & Gamble's Global Healthcare business, will become President and CEO on December 31, 2026, replacing Joseph M. Hogan, who has led the company since 2015 and will retire from the role and become a strategic advisor. Davis joins the Board as a director on November 2, 2026, and the filing sets out her pay package, including a $1,300,000 base salary and a $2,000,000 signing bonus. The change marks a planned leadership transition at the company, and the filing discloses no changes to financial results or guidance.
- Jennifer L. Davis joins as CEO-elect and director on November 2, 2026, and becomes President and CEO on December 31, 2026
- Joseph M. Hogan, CEO since 2015, retires as CEO on December 31, 2026 and will serve as a strategic advisor under a one-year consulting agreement with a $150,000 annual fee
- Davis's pay includes a $1,300,000 base salary, a 150% target bonus, equity awards of $9,900,000 and $6,600,000, and a $2,000,000 signing bonus
- Board size increases from ten to eleven directors effective November 2, 2026
Read the filing on SEC.gov ↗
Oct 28, 4:02 PM ET
Align Technology reported third-quarter 2026 results for the period ended September 30, 2026, with total revenue of $1.015 billion, up 1.9% from a year earlier, and GAAP diluted earnings of $1.90 per share, compared with $0.78 a year earlier. The company also gave fourth-quarter and full-year 2026 revenue ranges and said it expects to repurchase up to $300 million of stock in the fourth quarter.
- Q3 2026 net revenues were $1,014.8 million, up 1.9% year over year; Clear Aligner revenue rose 4.2% to $839.3 million
- Q3 2026 GAAP net income was $135.0 million, or $1.90 per diluted share, versus $0.78 in Q3 2025; non-GAAP diluted EPS was $2.80 versus $2.61
- Q4 2026 revenue is expected to be $1,000 million to $1,020 million; full-year 2026 revenue is expected to be $4,110 million to $4,130 million
- Company expects to repurchase about $500 million of its common stock in 2026, with up to $300 million planned for Q4; $630.0 million remained under the $1.0 billion program as of September 30, 2026
Read the filing on SEC.gov ↗
Aug 31, 4:05 PM ET
Align Technology appointed Quentin Blackford, 48, to its board on August 27, 2026, raising the board from ten to eleven directors. Director Andrea L. Saia, who has served since 2013, will resign effective September 23, 2026, returning the board to ten members, and the company says her decision was not due to any disagreement with the company.
- Quentin Blackford, 48, was appointed to the board on August 27, 2026. He is President and CEO of iRhythm Technologies, a role he has held since 2021.
- Andrea L. Saia will resign from the board effective September 23, 2026, and the filing says the resignation is not due to any disagreement or removal for cause.
- The board size goes from eleven to ten directors when Saia's resignation takes effect.
- Blackford is expected to stand for election at the 2027 annual meeting, expected in May 2027.
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.